As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him
Reversing a trend in which contributions from drugmakers’ political committees and their employees have gone largely to Republicans, so far for 2020 the industry has tilted toward Democrats.